Avadel Pharmaceuticals PLC (AD - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
AVDL Nasdaq 2834 https://www.avadel.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Avadel Pharmaceuticals PLC (AD

Avadel Pharmaceuticals Appoints Dr. Mark McCamish to its Board of Directors - Dec 10th, 2019 1:00 pm
Top Ranked Momentum Stocks to Buy for December 9th - Dec 9th, 2019 3:04 pm
All Eyes on These 3 Biotech Stocks Ahead of FDA Decisions - Dec 9th, 2019 2:18 pm
Brandes Investments' Top 5 Buys in the 3rd Quarter - Dec 6th, 2019 8:07 pm
Avadel Pharmaceuticals Announces Key Appointments to Leadership Team To Support Continued Transformation and the Advancement of FT218 - Dec 2nd, 2019 1:00 pm
Attention Biotech Investors: Mark Your Calendar For These December PDUFA Dates - Nov 29th, 2019 1:13 pm
Will Avadel Pharmaceuticals Continue to Surge Higher? - Nov 27th, 2019 12:01 pm
The Daily Biotech Pulse: ChemoCentryx Triples On Data Readout, Global Blood Given FDA Nod, Positive Safety Review For Genfit's NASH Drug - Nov 26th, 2019 1:06 pm
Avadel Pharmaceuticals Achieves Enrollment Target in REST-ON Phase 3 Pivotal Trial of FT218 for Excessive Daytime Sleepiness and Cataplexy in Patients with Narcolepsy - Nov 25th, 2019 1:00 pm
Avadel Pharmaceuticals to Present at Two Upcoming Investor Conferences - Nov 21st, 2019 1:00 pm
Jazz's (JAZZ) Sleep Drug Sunosi Nears Approval in Europe - Nov 18th, 2019 2:01 pm
The Avadel Pharmaceuticals (NASDAQ:AVDL) Share Price Is Up 41% And Shareholders Are Holding On - Nov 14th, 2019 10:14 am
Avadel Pharmaceuticals Reports Third Quarter 2019 Financial Results and Raises Revenue Guidance for FY2019 - Nov 12th, 2019 12:00 pm
Avadel Pharmaceuticals to Report Third Quarter 2019 Financial Results on November 12th - Oct 29th, 2019 12:00 pm
Avadel Announces Resignation of Kevin Kotler from Board of Directors - Oct 4th, 2019 8:05 pm
Avadel Pharmaceuticals Announces Pharmacokinetic (PK) Data for Once-Nightly FT218 that will be Included in an Oral Presentation at the World Sleep 2019 Congress on September 25th - Sep 24th, 2019 11:30 am
Avadel Pharma shares soar 22% premarket after FDA cuts sample size in trial of narcolepsy treatment - Sep 23rd, 2019 11:55 am
Avadel Pharmaceuticals Announces FDA Agreement to Reduce the Sample Size for the Ongoing Pivotal Phase 3 Study for Once-Nightly FT218; Full Enrollment Now Expected by End of 2019 - Sep 23rd, 2019 11:30 am
Avadel Pharmaceuticals Announces an Oral Presentation on Investigational Once-Nightly Sodium Oxybate (FT218) at the World Sleep 2019 Congress on September 25th - Sep 18th, 2019 11:30 am
Avadel Pharmaceuticals to Present at the Ladenburg Thalmann 2019 Healthcare Conference on September 24th - Sep 17th, 2019 11:30 am